Total amount raised
$12.5 Millions
Latest funding date
10/1/2020
Location
Loyal has successfully raised significant funding over multiple rounds, with its latest being a Series B. The company is dedicated to developing medicines aimed at extending the lifespan and improving the quality of life for dogs.
Keep reading to explore the intricacies of Loyal's fundraising journey and the investors backing this innovative biotechnology platform.
What Is Loyal?
Loyal, founded in 2019 by Celine Halioua, is a biotechnology company based in San Francisco, California. The company focuses on developing medicines to extend the lifespan and improve the quality of life for dogs.
With a team of 101-250 employees, Loyal aims to slow the aging process in dogs, targeting age-related diseases such as cancer and dementia. Their innovative approach seeks to quantify and regulate aging processes to ensure extended periods of improved health.
For more detailed information, you can visit their Crunchbase profile or their company website.
How Much Funding Has Loyal Raised?
- Seed Round
- Amount Raised: $11M
- Date: January 2020
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the company's research and development efforts.
- Venture Round
- Amount Raised: Not publicly disclosed
- Date: July 2020
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop their initial research and expand the team.
- Series A
- Amount Raised: $27M
- Date: September 2021
- Lead Investors: Khosla Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To advance preclinical studies and prepare for clinical trials.
- Series A
- Amount Raised: $20M
- Date: April 2022
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To continue clinical trials and expand research capabilities.
- Debt Financing
- Amount Raised: $12M
- Date: March 2024
- Lead Investors: Bridge Bank
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing operational expenses and clinical trials.
- Series B
- Amount Raised: $45M
- Date: March 2024
- Lead Investors: Bain Capital Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale up production and prepare for market entry.
- Series B-2
- Amount Raised: $22M
- Date: February 2025
- Lead Investors: Collaborative Fund, Valor Equity Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To advance clinical programs and prepare for potential commercialization.
Total Amount Raised: $137M. Current Valuation: Not publicly disclosed.
Key Investors
- Collaborative Fund
- Details: Collaborative Fund is a venture capital firm that focuses on early-stage investments in companies that are pushing the world forward. They have a strong emphasis on sustainability and social impact.
- Investment Focus Areas: Sustainability, health, consumer goods.
- Notable Investments: Lyft, Kickstarter, Beyond Meat.
- Valor Equity Partners
- Details: Valor Equity Partners is a growth-focused private equity firm that invests in high-growth companies across various sectors. They are known for their strategic involvement in their portfolio companies.
- Investment Focus Areas: Technology, consumer, healthcare.
- Notable Investments: Tesla, SpaceX, GoPuff.
- Bridge Bank
- Details: Bridge Bank provides financial services, including loans and credit facilities, to growing companies. They are a division of Western Alliance Bank.
- Investment Focus Areas: Financial services, loans, credit facilities.
- Notable Investments: Not publicly disclosed.
- Bain Capital Ventures
- Details: Bain Capital Ventures is a leading venture capital firm that invests from seed to growth stages. They are part of Bain Capital, a global private investment firm.
- Investment Focus Areas: Technology, healthcare.
- Notable Investments: LinkedIn, DocuSign, SurveyMonkey.
- Khosla Ventures
- Details: Khosla Ventures is a venture capital firm that invests in early to late-stage companies. They focus on impactful technology and sustainability solutions.
- Investment Focus Areas: Technology, healthcare, sustainability.
- Notable Investments: DoorDash, Square, Impossible Foods.
What's Next for Loyal?
With the recent FDA RXE acceptance for LOY-002, Loyal is poised to make significant strides in the veterinary pharmaceutical market. This regulatory milestone, coupled with their latest $22 million funding round, positions Loyal to potentially be the first to offer an FDA-approved longevity treatment for dogs. The market potential is vast, as pet owners increasingly seek ways to extend the lives of their beloved companions.
Future fundraising opportunities seem promising, given the strong investor confidence demonstrated by the substantial funds already raised. Loyal's ongoing clinical programs and preparation for commercialization suggest that additional rounds of funding may be on the horizon. However, the company will need to navigate the challenges of proving the efficacy of LOY-002 through clinical trials and gaining market acceptance from veterinarians and pet owners.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Loyal and gather other critical business insights. Sign up for free today and elevate your sales strategy with the power of detailed, actionable information.
